MedPath

The First Affiliated Hospital of Xinxiang Medical College

People's Republic of China
Ownership
Private
Established
1950-01-01
Employees
-
Market Cap
-
Website
http://www.gy120.net/

Clinical Trials

21

Active:0
Completed:1

Trial Phases

4 Phases

Phase 1:1
Phase 2:4
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials

Not Applicable
8 (57.1%)
Phase 2
4 (28.6%)
Phase 1
1 (7.1%)
Phase 3
1 (7.1%)

AI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001)

Not Applicable
Not yet recruiting
Conditions
Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition)
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Target Recruit Count
5000
Registration Number
NCT07136727
Locations
🇨🇳

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China

Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

Not yet recruiting
Conditions
Leukemia
Lymphoma
First Posted Date
2025-08-20
Last Posted Date
2025-08-20
Lead Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Target Recruit Count
200
Registration Number
NCT07131449

Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting

Not Applicable
Not yet recruiting
Conditions
Malignant Solid Tumors
Moderate to High Emetogenic Chemotherapy (MEC/HEC) Drugs
Interventions
Combination Product: high antiemetic regimen
Combination Product: moderate antiemetic regimen
Drug: Medroxyprogesterone acetate oral suspension
First Posted Date
2025-08-15
Last Posted Date
2025-08-15
Lead Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Target Recruit Count
126
Registration Number
NCT07124195
Locations
🇨🇳

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China

Clinical Transformation of Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Avascular Necrosis of Femur Head

Not Applicable
Not yet recruiting
Conditions
Avascular Necrosis of Femur Head
First Posted Date
2025-08-03
Last Posted Date
2025-08-03
Lead Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Target Recruit Count
30
Registration Number
NCT07101562
Locations
🇨🇳

The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan, China

Tissue Engineered Cartilage to Repairing Articular Cartilage Defects

Not Applicable
Not yet recruiting
Conditions
Cartilage Injury
OA Knee
First Posted Date
2025-07-30
Last Posted Date
2025-07-30
Lead Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Target Recruit Count
30
Registration Number
NCT07094100
Locations
🇨🇳

The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.